AzTrials
AzTrials

HemodynamicsCVPNCT01116973

Reliability of Central Venous Pressure Measurements

A study testing PICC in people with Hemodynamics and Central Venous Pressure, run by University of Oklahoma at 2 sites in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to compare CVP measurements from CICCs and PICCs. The investigators will also evaluate whether or not the duration of CICC placement affects the differences in CVP measurements between the CICCs and PICCs. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Hemodynamics, Central Venous Pressure
What is being tested?
PICC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
17 participants
Where
2 sitesUnited States
Study dates
2 Sep 2009to 27 Aug 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subject's ability to lay in a supine position with their hands at their sides during CVP measurements
  • A consent form signed by the patient or patient's representative
  • Subjects that are age 18-90
  • Subjects that have an indwelling CICC and are transitioning to a PICC for long-term IV access
  • CICC placed in the internal jugular vein or subclavian vein position

Who cannot join

  • Inability to obtain consent
  • Subjects under 18 years of age
  • Non-English speaking subjects
  • Subjects that are unable to lay flat due to pulmonary complications, increased intracranial pressure (ICP), or unstable spinal cord injuries
  • Subjects with known cardiac abnormalities (atrial septal defects or ventricular septal defects, severe tricuspid valve disease, severe pulmonary hypertension, Ejection fraction < 15%)
  • Prisoners
Show all 10Show fewer
  • Subjects with known upper extremity deep vein thromboses (subclavian or distal)
  • Subjects with non-functional CICC or PICC distal ports
  • Subjects with femoral CICCs
  • Pregnant women

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Univeristy of Oklahoma Health Sciences Center Dept. Anesthesiology

    Oklahoma City, Oklahoma, 73104

  • Univeristy of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, 73104

Other trials in United States

About this study

Official title: Reliability of Central Venous Pressure Measurements From Peripherally Inserted Central Catheters vs. Centrally Inserted Central Catheters

The purpose of this study is to compare CVP measurements from CICCs and PICCs. The investigators will also evaluate whether or not the duration of CICC placement affects the differences in CVP measurements between the CICCs and PICCs. The investigators hypothesize that the differences between the CVP measurements of the CICCs and PICCs will be clinically insignificant.

Read the detailed description

Centrally inserted central catheters (CICC) are commonly used in the intensive care unit (ICU) for delivery of fluids, medications, and nutrition. They are also used to measure central venous pressure (CVP) which provides critical information about blood volume status and cardiac function of a patient. Currently, CICCs are the gold standard for measuring CVP, but they have a number of associated risks including pneumothorax, major hemorrhage, neck hematoma, and carotid puncture. An alternative to a CICC is a peripherally inserted central catheter (PICC). A PICC can be placed with lower risks than a CICC, has a lower rate of bloodstream infections, and provides longer-term IV access at a lower cost. PICCs can be used to deliver fluids, medications, and nutrition. However, there is minimal evidence that a PICC can measure CVP as effectively as a CICC. Therefore, a CICC is preferred when a patient requires CVP monitoring in our ICU. Our aim is to compare CVP measurements from CICCs and PICCs. We will also evaluate whether or not the duration of CICC placement affects the differences in CVP measurements between the CICCs and PICCs. We hypothesize that the differences between the CVP measurements of the CICCs and PICCs will be clinically insignificant.

The goal of this study is to determine if the central venous pressure (CVP) measurements obtained from a peripherally inserted central catheter (PICC) consistently correlate with the CVP measurements obtained from a centrally inserted central catheter (CICC). If the difference between the CVP measurements from the CICC and PICC are found to be clinically insignificant, then it may be practical to place PICCs in favor of CICCs thereby avoiding some of the potential complications associated with CICC placement. We also aim to evaluate whether or not the duration of CICC placement affects the differences in CVP measurements between the CICCs and PICCs. We hypothesize that the differences between the CVP measurements of the CICCs and PICCs will be clinically insignificant.

Being tested
PICC
Keywords
CVP monitoring compared with peripheral monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PICCOther

    Also called 18-gauge double lumen PICC

    Peripheral inserted catheter placement to take the reading

Study groups in NCT01116973
Study groupRoleWhat they receive
CICC comparison with PICCOtherAll patients will be having CVP reading taken from the CICC
Receives: Other: PICC
PICC groupOtherThe transition to the PICC, a 5.0-French, 18-gauge double lumen PICC (BARD, Power PICC Solo Catheter with Tip Location Stylet; Salt Lake City, UT) will be inserted
Receives: Other: PICC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Central venous pressure comparison with peripheral venous pressure

    We will compare the realiablity of reading collected via central venous pressure reading and compare it with peripheral venous pressure reading.

    Measured: 1 year

Secondary outcomes (1)
  1. CICC reading comparison with PICC

    This might also reduce the complications associated with CICC procedures

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2010 (estimated)
  2. Study start2 Sep 2009
  3. Primary completion27 Aug 2016
  4. Study completion27 Aug 2016

Why it stopped: Change in guidelines by the manufacturer.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
17 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01116973
Sponsor's protocol ID
1911
Acronym
CVP
Status last verified
May 2017
First submitted
3 May 2010
Last updated
4 May 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing PICC in people with Hemodynamics and Central Venous Pressure, run by University of Oklahoma at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 4 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Change in guidelines by the manufacturer.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Central venous pressure comparison with peripheral venous pressure (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in